688253 英诺特
已收盘 12-31 15:00:00
资讯
新帖
简况
英诺特：天弘基金投资者于12月9日调研我司
证券之星 · 2025-12-15
英诺特：天弘基金投资者于12月9日调研我司
英诺特（688253）披露近期获得资质情况，12月1日股价下跌1.39%
证券之星 · 2025-12-01
英诺特（688253）披露近期获得资质情况，12月1日股价下跌1.39%
每周股票复盘：英诺特（688253）推股东回馈活动赠iPhone17等
证券之星 · 2025-11-23
每周股票复盘：英诺特（688253）推股东回馈活动赠iPhone17等
每周股票复盘：英诺特（688253）Q3呼吸道产品仍为主要收入来源
证券之星 · 2025-11-16
每周股票复盘：英诺特（688253）Q3呼吸道产品仍为主要收入来源
英诺特（688253）2025年三季报简析：净利润同比下降46.37%，三费占比上升明显
证券之星 · 2025-11-01
英诺特（688253）2025年三季报简析：净利润同比下降46.37%，三费占比上升明显
股市必读：英诺特三季报 - 第三季度单季净利润同比下降84.04%
证券之星 · 2025-10-31
股市必读：英诺特三季报 - 第三季度单季净利润同比下降84.04%
英诺特(688253.SH)发布前三季度业绩，归母净利润1.31亿元，同比下降46.37%
智通财经 · 2025-10-30
英诺特(688253.SH)发布前三季度业绩，归母净利润1.31亿元，同比下降46.37%
英诺特(688253)9月30日股东户数0.8万户，较上期增加10.57%
证券之星 · 2025-10-30
英诺特(688253)9月30日股东户数0.8万户，较上期增加10.57%
每周股票复盘：英诺特（688253）限制性股票归属526,120股上市
证券之星 · 2025-09-28
每周股票复盘：英诺特（688253）限制性股票归属526,120股上市
英诺特（688253）披露限制性股票激励计划归属结果暨股份上市公告，9月26日股价上涨0.68%
证券之星 · 2025-09-26
英诺特（688253）披露限制性股票激励计划归属结果暨股份上市公告，9月26日股价上涨0.68%
英诺特（688253）披露2025年半年度持续督导跟踪报告，9月17日股价上涨0.69%
证券之星 · 2025-09-17
英诺特（688253）披露2025年半年度持续督导跟踪报告，9月17日股价上涨0.69%
英诺特：选举陈廷友先生为公司第二届董事会职工代表董事
证券日报网 · 2025-09-15
英诺特：选举陈廷友先生为公司第二届董事会职工代表董事
股市必读：英诺特中报 - 第二季度单季净利润同比下降50.51%
证券之星 · 2025-09-01
股市必读：英诺特中报 - 第二季度单季净利润同比下降50.51%
每周股票复盘：英诺特（688253）中报营收降34.35%
证券之星 · 2025-08-31
每周股票复盘：英诺特（688253）中报营收降34.35%
英诺特（688253）2025年中报简析：净利润同比下降39.36%，三费占比上升明显
证券之星 · 2025-08-30
英诺特（688253）2025年中报简析：净利润同比下降39.36%，三费占比上升明显
英诺特2025年1-6月净利润为1.25亿元，较去年同期下滑39.36%
金融界 · 2025-08-28
英诺特2025年1-6月净利润为1.25亿元，较去年同期下滑39.36%
英诺特：上半年净利润1.25亿元，同比下降39.36%
格隆汇 · 2025-08-28
英诺特：上半年净利润1.25亿元，同比下降39.36%
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
国金证券 · 2025-08-10
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
个股概念调整|英诺特新增“肝炎概念”概念
市场透视 · 2025-08-05
个股概念调整|英诺特新增“肝炎概念”概念
猴痘概念盘中跳水，义翘神州跌1.06%
市场透视 · 2025-08-04
猴痘概念盘中跳水，义翘神州跌1.06%
加载更多
公司概况
公司名称：
北京英诺特生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-07-28
主营业务：
北京英诺特生物技术股份有限公司的主营业务是POCT快速诊断产品研发、生产和销售。公司的主要产品是呼吸道系列、优生优育系列、其他试剂系列、POCT诊断仪器。
发行价格：
26.06
{"stockData":{"symbol":"688253","market":"SH","secType":"STK","nameCN":"英诺特","latestPrice":30.18,"timestamp":1767164400000,"preClose":30.33,"halted":0,"volume":958551,"delay":0,"changeRate":-0.0049,"floatShares":69336800,"shares":137000000,"eps":0.9742,"marketStatus":"已收盘","change":-0.15,"latestTime":"12-31 15:00:00","open":30.35,"high":30.57,"low":30.16,"amount":29036700,"amplitude":0.0135,"askPrice":30.18,"askSize":7,"bidPrice":30.17,"bidSize":16,"shortable":0,"etf":0,"ttmEps":0.9742,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767576600000},"marketStatusCode":5,"adr":0,"adjPreClose":30.33,"symbolType":"stock_kcb","openAndCloseTimeList":[[1767144600000,1767151800000],[1767157200000,1767164400000]],"highLimit":33.36,"lowLimit":27.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":136984316,"isCdr":false,"pbRate":2.03,"roa":"--","peRate":30.979265,"roe":"6.5%","epsLYR":1.81,"committee":0.340996,"marketValue":4134000000,"turnoverRate":0.0138,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-01-05。","afterMarket":{"amount":0,"volume":0,"close":30.18,"buyVolume":0,"sellVolume":0,"time":1767166437558,"indexStatus":"已收盘 12-31 15:30:00","preClose":30.33},"floatMarketCap":2093000000},"requestUrl":"/m/hq/s/688253","defaultTab":"news","newsList":[{"id":"2591612644","title":"英诺特：天弘基金投资者于12月9日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2591612644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591612644?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:43","pubTimestamp":1765791783,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年12月15日英诺特发布公告称天弘基金吕俏 刘盟盟 李佳豪 钟颖 张秀磊于2025年12月9日调研我司。公司对相关项目的研判及决策较为审慎，具体进展情况公司将按照相关监管规则及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2588077550","title":"英诺特（688253）披露近期获得资质情况，12月1日股价下跌1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588077550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588077550?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:26","pubTimestamp":1764599165,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，英诺特报收于34.06元，较前一交易日下跌1.39%，最新总市值为46.66亿元。该股当日开盘34.54元，最高35.11元，最低33.93元，成交额达8292.61万元，换手率为3.49%。公司近日发布关于近期获得资质情况的自愿披露公告。公告称，北京英诺特生物技术股份有限公司近期取得一项新产品资质，获批产品为幽门螺杆菌抗原检测试剂盒（乳胶法），注册证号为国械注准20253402376，发证日期为2025年11月25日，有效期至2030年11月24日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100036897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2585103404","title":"每周股票复盘：英诺特（688253）推股东回馈活动赠iPhone17等","url":"https://stock-news.laohu8.com/highlight/detail?id=2585103404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585103404?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:49","pubTimestamp":1763837351,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，英诺特报收于30.49元，较上周的35.05元下跌13.01%。本周，英诺特11月17日盘中最高价报35.78元。英诺特当前最新总市值41.77亿元，在医疗器械板块市值排名77/126，在两市A股市值排名3692/5167。本周关注点公司公告汇总：英诺特联合同花顺开展股东回馈活动，奖品含iPhone 17 Pro Max、大疆无人机及自产检测试剂盒。报名后经身份认证，于12月1日开奖，中奖者需在12月10日前填写邮寄信息。本次活动为自愿性信息披露，不影响公司经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2583654862","title":"每周股票复盘：英诺特（688253）Q3呼吸道产品仍为主要收入来源","url":"https://stock-news.laohu8.com/highlight/detail?id=2583654862","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583654862?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:18","pubTimestamp":1763237895,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，英诺特报收于35.05元，较上周的34.35元上涨2.04%。本周，英诺特11月10日盘中最高价报36.4元。英诺特当前最新总市值48.01亿元，在医疗器械板块市值排名76/126，在两市A股市值排名3482/5165。来自机构调研要点：2025年Q3毛利率与净利率同比下滑，主要受流行病趋势及税收政策影响。2025年第三季度，呼吸道病原体检测相关产品营业收入仍是公司营业收入主要组成部分，相关产品营业收入及增速与公司整体营业收入趋势基本一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"gpt_icon":0},{"id":"2580393417","title":"英诺特（688253）2025年三季报简析：净利润同比下降46.37%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2580393417","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580393417?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:49","pubTimestamp":1761950972,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期英诺特发布2025年三季报。截至本报告期末，公司营业总收入3.3亿元，同比下降36.56%，归母净利润1.31亿元，同比下降46.37%。按单季度数据看，第三季度营业总收入5396.95万元，同比下降45.9%，第三季度归母净利润611.8万元，同比下降84.04%。本报告期英诺特三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达37.3%。去年的净利率为39.73%，算上全部成本后，公司产品或服务的附加值极高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"gpt_icon":0},{"id":"2579109281","title":"股市必读：英诺特三季报 - 第三季度单季净利润同比下降84.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109281","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579109281?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:29","pubTimestamp":1761863374,"startTime":"0","endTime":"0","summary":"业绩披露要点财务报告英诺特2025年三季报显示，前三季度实现营业收入3.3亿元，同比下降36.56%；归母净利润1.31亿元，同比下降46.37%；扣非净利润1.12亿元，同比下降49.96%。2025年第三季度单季度营业收入5396.95万元，同比下降45.9%；单季度归母净利润611.8万元，同比下降84.04%；单季度扣非净利润93.04万元，同比下降97.13%。归属于上市公司股东的净利润本报告期为611.80万元，同比下降84.04%；年初至报告期末为1.31亿元，同比下降46.37%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100008279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"gpt_icon":1},{"id":"2579611331","title":"英诺特(688253.SH)发布前三季度业绩，归母净利润1.31亿元，同比下降46.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579611331","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579611331?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:38","pubTimestamp":1761817131,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英诺特(688253.SH)披露2025年第三季度报告，公司前三季度实现营收3.3亿元，同比下降36.56%;归母净利润1.31亿元，同比下降46.37%;扣非净利润1.12亿元，同比下降49.96%;基本每股收益0.96元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362822.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"英诺特(688253.SH)发布前三季度业绩，归母净利润1.31亿元，同比下降46.37%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688253"],"gpt_icon":0},{"id":"2579358118","title":"英诺特(688253)9月30日股东户数0.8万户，较上期增加10.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579358118","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579358118?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:28","pubTimestamp":1761816521,"startTime":"0","endTime":"0","summary":"证券之星消息，近日英诺特披露，截至2025年9月30日公司股东户数为8037.0户，较6月30日增加768.0户，增幅为10.57%。在医疗器械行业个股中，英诺特股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2025年6月30日至2025年9月30日，英诺特区间跌幅为0.36%，在此期间股东户数增加768.0户，增幅为10.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000033150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"gpt_icon":0},{"id":"2570891742","title":"每周股票复盘：英诺特（688253）限制性股票归属526,120股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2570891742","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570891742?lang=zh_cn&edition=full","pubTime":"2025-09-28 03:32","pubTimestamp":1759001534,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，英诺特报收于31.12元，较上周的30.9元上涨0.71%。公司公告汇总北京英诺特生物技术股份有限公司完成2023年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期的股份登记。本次归属合计76人，其中首次授予57人，预留授予19人，共归属526,120股，来源为公司向激励对象定向发行A股普通股。上市流通日为2025年9月30日，上市流通数量为526,120股。本次归属后公司总股本由136,458,196股增至136,984,316股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800000818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2570009887","title":"英诺特（688253）披露限制性股票激励计划归属结果暨股份上市公告，9月26日股价上涨0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570009887","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570009887?lang=zh_cn&edition=full","pubTime":"2025-09-26 17:27","pubTimestamp":1758878826,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，英诺特报收于31.12元，较前一交易日上涨0.68%，最新总市值为42.63亿元。该股当日开盘30.92元，最高31.34元，最低30.53元，成交额达5763.17万元，换手率为2.67%。公司于近日发布公告，披露2023年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期的归属结果暨股份上市情况。上市流通日为2025年9月30日，上市流通数量为526,120股。本次归属后公司总股本由136,458,196股增至136,984,316股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600027889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2568497448","title":"英诺特（688253）披露2025年半年度持续督导跟踪报告，9月17日股价上涨0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568497448","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568497448?lang=zh_cn&edition=full","pubTime":"2025-09-17 22:56","pubTimestamp":1758120978,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，英诺特报收于30.85元，较前一交易日上涨0.69%，最新总市值为42.1亿元。近日，华泰联合证券有限责任公司发布关于北京英诺特生物技术股份有限公司2025年半年度持续督导跟踪报告。公告显示，华泰联合证券对英诺特2025年上半年持续督导期间，确认公司治理、内部控制及信息披露制度得到有效执行，未发现公司存在重大违法违规或违背承诺事项的情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"gpt_icon":0},{"id":"2567148336","title":"英诺特：选举陈廷友先生为公司第二届董事会职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2567148336","media":"证券日报网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567148336?lang=zh_cn&edition=full","pubTime":"2025-09-15 21:39","pubTimestamp":1757943540,"startTime":"0","endTime":"0","summary":"证券日报网讯9月15日晚间，英诺特发布公告称，同意选举陈廷友先生为公司第二届董事会职工代表董事。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-15/doc-infqqytz4305710.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-15/doc-infqqytz4305710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2564485072","title":"股市必读：英诺特中报 - 第二季度单季净利润同比下降50.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564485072","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564485072?lang=zh_cn&edition=full","pubTime":"2025-09-01 06:47","pubTimestamp":1756680430,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，英诺特报收于31.33元，下跌1.69%，换手率5.99%，成交量4.12万手，成交额1.29亿元。来自业绩披露要点：2025年第二季度单季度归母净利润同比下降50.51%。股本股东变化股东户数变动近日英诺特披露，截至2025年6月30日公司股东户数为7269.0户，较3月31日减少220.0户，减幅为2.94%。关于变更注册资本、取消监事会及修订《公司章程》并办理工商登记的公告北京英诺特生物技术股份有限公司拟变更注册资本，由13,606.0816万元变更为13,645.8196万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100000914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"gpt_icon":0},{"id":"2563887024","title":"每周股票复盘：英诺特（688253）中报营收降34.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563887024","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563887024?lang=zh_cn&edition=full","pubTime":"2025-08-31 05:44","pubTimestamp":1756590256,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，英诺特报收于31.33元，较上周的32.94元下跌4.89%。本周，英诺特8月26日盘中最高价报33.6元。英诺特当前最新总市值42.75亿元，在医疗器械板块市值排名88/126，在两市A股市值排名3697/5152。本周关注点业绩披露要点：英诺特2025年中报显示，公司主营收入2.76亿元，同比下降34.35%。股本股东变化截至2025年6月30日，英诺特股东户数为7,269户，较3月31日减少220户，减幅2.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100000931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"gpt_icon":0},{"id":"2563070501","title":"英诺特（688253）2025年中报简析：净利润同比下降39.36%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2563070501","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563070501?lang=zh_cn&edition=full","pubTime":"2025-08-30 06:16","pubTimestamp":1756505793,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期英诺特发布2025年中报。截至本报告期末，公司营业总收入2.76亿元，同比下降34.35%，归母净利润1.25亿元，同比下降39.36%。按单季度数据看，第二季度营业总收入6946.07万元，同比下降50.19%，第二季度归母净利润2978.01万元，同比下降50.51%。本报告期英诺特三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达47.9%。去年的净利率为39.73%，算上全部成本后，公司产品或服务的附加值极高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000010592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"gpt_icon":0},{"id":"2562105192","title":"英诺特2025年1-6月净利润为1.25亿元，较去年同期下滑39.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562105192","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562105192?lang=zh_cn&edition=full","pubTime":"2025-08-28 23:19","pubTimestamp":1756394342,"startTime":"0","endTime":"0","summary":"英诺特半年报数据显示，2025年1-6月营业总收入为2.76亿元，较去年同期下滑34.35%，净利润为1.25亿，较去年同期下滑39.36%，每股收益0.92元，净资产收益率为5.91%，每股经营现金流量为0.6264元，销售毛利率为80.40%，所处行业为生物制品。资料显示，英诺特成立于2006年，位于北京市丰台区海鹰路1号院6号楼1层2层，是一家以从事POCT快速诊断产品研发、生产和销售为主的企业。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/28231952789254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688253"],"gpt_icon":0},{"id":"2562581340","title":"英诺特：上半年净利润1.25亿元，同比下降39.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562581340","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562581340?lang=zh_cn&edition=full","pubTime":"2025-08-28 21:36","pubTimestamp":1756388218,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","688253"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持，行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高，支持性政策在产品注册、医保支付、行业标准等层面均有体现。1）在产品注册方面，国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策，脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688236","603309","688075","688114","688068","688366","688755","688575","688656","688767","688289","688617","603976","603658","605369","603387","688026","688277","600645","688298","688198","688576","688193","688314","688139","688426","600807","688050","688393","688338","688606","688273","600529","600587","688677","688108","688217","560260","688389","688581","603222","688351","688271","688468","688085","688613","688151","688016","603014","688317","688358","688029","688067","688580","688253","688410","603987","603880","159883","688013","688212","688301","688607","603205","600055","688161"],"gpt_icon":0},{"id":"2557367037","title":"个股概念调整|英诺特新增“肝炎概念”概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2557367037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557367037?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:15","pubTimestamp":1754378133,"startTime":"0","endTime":"0","summary":"2025年08月05日，英诺特新增了肝炎概念概念。英诺特的所属概念，还有：融资融券、病毒检测、流感、猴痘、转融券标的、科创企业同股同权。个股概念调整既是市场认知的再校准，也是企业战略的显性化映射。对于投资者而言：①概念新增往往预示新业务增长点的价值重估窗口 ②概念移除需警惕业务收缩或市场预期修正风险 ③交叉验证财务数据与概念含金量是避免\"伪概念\"陷阱的关键 ④关注机构持仓变化与概念调整的协同性可捕捉主力动向。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805151537a6d3ed43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805151537a6d3ed43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688253","BK0239"],"gpt_icon":0},{"id":"2556742168","title":"猴痘概念盘中跳水，义翘神州跌1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556742168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556742168?lang=zh_cn&edition=full","pubTime":"2025-08-04 09:46","pubTimestamp":1754271983,"startTime":"0","endTime":"0","summary":"08月04日，猴痘概念盘中跳水，截至09点46分，猴痘概念整体指数下跌1.05%，报1112.230点。从个股上来看，该概念的成分股中，义翘神州跌1.06%，英诺特、博拓生物、新产业跌幅居前。从资金上来看，截止发稿，猴痘概念主力净流入为-1.64亿，其中海辰药业受到资金热捧，主力净流入5742.39万；拉长时间线来看，该板块近20日主力资金净流入-35.63亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094623a6d138c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094623a6d138c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688767","688253","BK0216","301047","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767526916504,"stockEarnings":[{"period":"1week","weight":-0.0268},{"period":"1month","weight":-0.1139},{"period":"3month","weight":-0.0185},{"period":"6month","weight":0.0033},{"period":"1year","weight":-0.1524},{"period":"ytd","weight":-0.1524}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.143},{"period":"1year","weight":0.1841},{"period":"ytd","weight":0.1841}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京英诺特生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8037人(较上一季度增加10.57%)","perCapita":"8627股","listingDate":"2022-07-28","address":"北京市丰台区海鹰路1号院6号楼1层2层","registeredCapital":"13698万元","survey":" 北京英诺特生物技术股份有限公司的主营业务是POCT快速诊断产品研发、生产和销售。公司的主要产品是呼吸道系列、优生优育系列、其他试剂系列、POCT诊断仪器。","listedPrice":26.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英诺特(688253)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英诺特(688253)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英诺特,688253,英诺特股票,英诺特股票老虎,英诺特股票老虎国际,英诺特行情,英诺特股票行情,英诺特股价,英诺特股市,英诺特股票价格,英诺特股票交易,英诺特股票购买,英诺特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英诺特(688253)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英诺特(688253)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}